Background

Beverley Moore is an associate in the Ottawa office of Borden Ladner Gervais LLP. Beverley is a lawyer. She obtained an Honours Bachelor of Science in Biochemistry in 1997, a Master of Science in Biochemistry in 2000 and an Bachelor of Laws in 2002, all from Queen's University. Beverley's Masters research involved mechanistic studies with Vitamin D analogues. Beverley was called to the Ontario bar in 2003.

Areas of Practice

• intellectual property litigation, with an emphasis on patent litigation and applications under the NOC Regulations
• regulatory issues such as listing patents on the Patent Register; reporting patents to the Patented Medicines Prices Review Board, patent portfolio management and the Register of Innovative Drugs as it relates to data protection

Professional Experience

• appeared before the Federal Court and the Federal Court of Appeal
• represented pharmaceutical companies in patent infringement actions, applications under the NOC Regulations, damages proceedings under the NOC Regulations, and judicial reviews of decisions of the Minister of Health

Selected Recent Professional Publications and Speaking Engagements

• BLG Intellectual Property Weekly Abstracts Bulletin (co-author and co-editor)
• “The Canadian Patent Register: Your Shield Against Premature Generic Competition” Pharma & BioPharma Industry Guide (January 2011)
• "Fitting Biologic Products into the Data Protection and Notice of Compliance Regulatory Schemes" Canadian Biotechnology Industry Guide 2011 (January 2011)
• "A Product's Lifecycle from Innovation to Commercialization: The Patented Medicines (Notice of Compliance) Regulations , the Patent Act and Data Protection” Life Sciences BC (31/03/2011)
• "Clinical Trials and their Presence in Patent Cases" Insights Clinical Trials in Canada (15/04/1011)
• “Update on intellectual property protection for biotechnology in Canada ” BIOTECanada insights (Fall 2010)
• Exploiting New Opportunities in Biologics and Subsquent Entry Biologics: “A Brief Discussion of Legal Issues Surrounding the Guidance Document Regarding Subsequent Entry Biologics” 9th Annual Forum on Pharma Patents (4/11/2010)
• “Disclosure Requirements Increased” Managing Intellectual Property (01/10/2010)

Professional and Community Activities

• Member of the Intellectual Property Owners Association (IPO), and the IPO Patent Law and Practice (International) Committee
• Member of the IP Section of the American Bar Association, (ABA), and the Committees on Patents in the Chemical & Life Sciences and International Patent Treaties & Laws
• Member of BIOTECanada’s Health Advisory Board and Biologic and Regulatory Affairs Group
• Member of the Canadian Bar Association (CBA), Intellectual Property Institute of Canada (IPIC),  American Intellectual Property Law Association (AIPLA), Carleton County Law Association (CCLA)